XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.3
Net Loss per Share
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Net Loss per Share Net Loss per Share
The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have been anti-dilutive:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Outstanding stock options1,829,324 658,417 1,829,324 658,417 
Unvested restricted stock units222,674 42,241 222,674 42,241 
Potential shares issuable under the 2020 ESPP7,391 10,780 7,391 10,780 
2,059,389 711,438 2,059,389 711,438 
Common shares issuable upon exercise of the pre-funded warrants that were sold in connection with the June 2023, January 2024, and April 2024 underwritten public offering are included in the calculation of basic weighted average number of common shares outstanding for the three and nine months ended September 30, 2024. Consistent with the guidance in ASC 260-10-45-13, the underlying common shares are issuable for little to no consideration and there are no vesting conditions or contingencies associated with the warrants. Accordingly, the aggregate number of common shares underlying the pre-funded warrants have been considered outstanding for purposes of the calculation of basic net loss per share from the date of issuance.